IRIS UniCatt

Tamburrini, Enrica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.148
AS - Asia 4.138
EU - Europa 4.074
SA - Sud America 790
Continente sconosciuto - Info sul continente non disponibili 195
AF - Africa 146
OC - Oceania 33
Totale 17.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.908
SG - Singapore 1.919
CN - Cina 854
IT - Italia 806
DE - Germania 804
BR - Brasile 659
SE - Svezia 622
FR - Francia 544
VN - Vietnam 373
UA - Ucraina 272
GB - Regno Unito 250
IE - Irlanda 204
IN - India 167
FI - Finlandia 149
CA - Canada 137
ID - Indonesia 123
BD - Bangladesh 99
JP - Giappone 99
HK - Hong Kong 97
PL - Polonia 92
RU - Federazione Russa 77
TR - Turchia 63
MX - Messico 57
IQ - Iraq 49
AR - Argentina 47
NL - Olanda 45
PK - Pakistan 42
AT - Austria 37
ZA - Sudafrica 36
SA - Arabia Saudita 34
BE - Belgio 31
AU - Australia 28
ES - Italia 28
KR - Corea 27
IR - Iran 26
MA - Marocco 23
PH - Filippine 23
CI - Costa d'Avorio 19
EG - Egitto 19
MY - Malesia 17
CH - Svizzera 16
CO - Colombia 16
EC - Ecuador 15
RO - Romania 15
UZ - Uzbekistan 15
VE - Venezuela 15
IL - Israele 12
JO - Giordania 12
LT - Lituania 12
PE - Perù 12
PY - Paraguay 12
KE - Kenya 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
KZ - Kazakistan 9
NP - Nepal 9
GR - Grecia 8
EU - Europa 7
MD - Moldavia 7
HN - Honduras 6
PT - Portogallo 6
TH - Thailandia 6
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
DZ - Algeria 5
ET - Etiopia 5
GT - Guatemala 5
NI - Nicaragua 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HR - Croazia 4
JM - Giamaica 4
KG - Kirghizistan 4
KH - Cambogia 4
PA - Panama 4
PR - Porto Rico 4
TW - Taiwan 4
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
SD - Sudan 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
BW - Botswana 2
CM - Camerun 2
DK - Danimarca 2
Totale 17.298
Salva come PNG Salva come JPEG
Città #
Singapore 1.013
Chandler 740
Ashburn 689
San Jose 631
New York 209
Dublin 198
Beijing 168
Jacksonville 160
Milan 155
Rome 155
San Mateo 149
Los Angeles 148
Dallas 129
Ho Chi Minh City 127
Lauterbourg 113
Jakarta 111
Hanoi 96
Tokyo 91
Ann Arbor 88
Atlanta 86
Hefei 85
Nanjing 84
Wilmington 84
Hong Kong 77
The Dalles 73
Chicago 72
Dearborn 71
Frankfurt am Main 68
Helsinki 67
Boston 66
Munich 66
São Paulo 61
St Louis 55
Kraków 53
Moscow 53
Woodbridge 50
Princeton 49
Houston 48
Marseille 48
Boardman 46
Lawrence 43
Cattolica 40
Buffalo 39
Santa Clara 39
Seattle 39
Izmir 34
Orem 33
Montreal 31
Nuremberg 31
Bremen 30
Lancaster 30
London 30
Memphis 29
Redwood City 29
Toronto 29
Brooklyn 28
Paris 28
Brussels 27
Denver 27
Nürnberg 27
Rio de Janeiro 27
Chennai 26
Warsaw 26
Nanchang 24
Amsterdam 23
Vienna 23
Augusta 22
Council Bluffs 22
Norwalk 22
Ottawa 22
Da Nang 21
Phoenix 21
San Francisco 21
Tukwila 21
Fairfield 20
Kent 20
Poplar 20
Stockholm 20
Manchester 19
Mexico City 19
Mountain View 19
Trieste 19
Abidjan 18
Düsseldorf 18
Guangzhou 18
Johannesburg 18
Pune 18
Seoul 18
Dhaka 17
Haiphong 17
Hangzhou 17
Tianjin 17
Turku 17
Washington 17
Dammam 16
University Park 16
Belo Horizonte 15
Hebei 15
Lahore 15
Jiaxing 14
Totale 7.953
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 530
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 416
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 335
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 320
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 295
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 294
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 291
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 282
Rubella susceptibility profile in pregnant women with HIV 272
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 271
Rubella susceptibility profile in pregnant women with HIV 260
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 244
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001-2011 243
Excretion of SARS-CoV-2 in human breast milk 239
Glucose plasma levels and pregnancy outcomes in women with HIV 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 237
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens 235
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine 231
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 216
Pregnancy outcomes in women with advanced HIV infection in Italy 216
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 211
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 206
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 204
Assessment of neurological manifestations in hospitalized patients with COVID-19 203
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 201
Residual respiratory impairment after COVID-19 pneumonia 199
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 196
Residual respiratory impairment after COVID-19 pneumonia 181
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 179
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 179
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 174
Migranti cinesi in gravidanza: stato sierologico relativo alle principali malattie infettive ed accesso ai servizi sanitari. L’esperienza nelle comunità di Roma e Prato 172
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 172
Sarilumab use in severe SARS-CoV-2 pneumonia 170
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 169
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 168
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 166
Cognitive reserve and neuropsychological functioning in older HIV-infected people 166
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 161
Oral lesions in HIV and HCV co-infected individuals in HAART era 160
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 160
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 159
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 158
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 157
Dental care and HIV-infected individuals: are they equally treated? 156
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 156
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 155
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 154
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 152
Oral lesions in HIV and HCV co-infected individuals in HAART era 148
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 146
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 143
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 143
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 140
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 138
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 138
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 128
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 128
Pregnancy outcomes in women with advanced HIV infection in Italy 127
Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women 126
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 125
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 122
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 122
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 120
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 120
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 119
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. 119
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: A multicentre case series 118
Risk factors for bloodstream infections in gynecological cancer 116
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 114
Is smallpox vaccination protective against human monkeypox? 114
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 112
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 111
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 111
Antiretroviral treatment in pregnancy: a six-years perspective on recent trands in prescription patterns, viral load suppression, and pregnancy outcomes. 110
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 110
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 109
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 108
Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2 108
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 107
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study 107
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 106
Glucose plasma levels and pregnancy outcomes in women with HIV 105
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 105
HCV–HIV coinfected pregnant women: data from a multicentre study in Italy 103
People Living with HIV in the COVID-19 Era: A Case Report 103
Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop 102
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 102
In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers 99
Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy 99
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 99
COVID-19 diagnosis does not rule out other concomitant diseases 97
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 96
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 96
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 94
People Living with HIV in the COVID-19 Era: A Case Report 92
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 92
Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero 91
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 91
Autochthonous dengue outbreak in Rome, Italy, in 2023 90
Totale 16.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 0 63 22 67 35 24 37 160 37 67 135 197
2022/20232.424 252 284 213 405 235 311 105 176 254 78 85 26
2023/20241.197 45 295 39 75 63 202 76 33 35 59 116 159
2024/20252.312 39 59 226 75 196 79 108 107 385 226 449 363
2025/20265.672 781 188 371 616 996 296 991 267 398 444 192 132
2026/20272.592 192 2.400 0 0 0 0 0 0 0 0 0 0
Totale 17.524